1. Patient-derived xenograft (PDX) models of BRCA-deficient and BRCA-like ovarian tumors reflect clinical responses to PARP inhibition. (December 2016) Authors: Davies, A.; Hou, J.; Shih, L.M.; Wright, J.D.; Ciznadija, D.; Katz, A.; Sidransky, D. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S110 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗